Moreover, suppression of Protein arginine methyltransferase 5 (PRMT5) by two orthogonal-acting inhibitors (GSK591 or LLY-283), was shown to reduce the growth of GBM stem cell cultures derived from 46 patients [172]. This evidence concerns the gene PRMT5 and glioblastoma.